Cancers induced by alpha particles from Thorotrast

International Congress Series

Volumn 1236, Issue C, 2002, Pages 191-194

  Ishikawa, Yuichi ^a   Wada, Ikuo ^a   Fukumoto, Manabu ^b  

^a CANCER INSTITUTE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Alpha particle; Cancer; Genetic changes; Radiation; Thorotrast

Indexed keywords

EID: 85014243837     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0531-5131(01)00756-7     Document Type: Article

References (12)

1. Mori, T., Kido, C., Fukutomi, K., Kato, Y., Hatakeyama, S., Machinami, R., Ishikawa, Y., Kumatori, T., Sasaki, F., Hirota, Y., Kiyasawa, K., Hayashi, S., Tanooka, H., Sobue, T., Summary of entire Japanese Thorotrast follow-up study: updated 1998. Radiat. Res. 152:Suppl. 6 (1999 Dec.), S84–S87 (supplement).
2. van Kaick, G., Dalheimer, A., Hornik, S., Kaul, A., Liebermann, D., Luehrs, H., Spiethoff, A., Wegener, K., Wesch, H., The German Thorotrast study: recent results and assessment of risks. Radiat. Res. 152:Suppl. 6 (1999 Dec.), S64–S71 (supplement).
3. Andersson, M., Long-term effects of internally deposited alpha-particle emitting radionuclides: epidemiological, pathological and molecular biological studies of Danish Thorotrast-administered patients and their offspring. Danish Med. Bull. 44 (1997), 169-190.
4. Ishikawa, Y., Mori, T., Kato, Y., Tsuchiya, E., Machinami, R., Sugano, H., Kitagawa, T., Lung cancers associated with Thorotrast exposure: high incidence of small cell carcinoma and implications for estimation of radon risk. Int. J. Cancer 52 (1992), 570-574.
5. Ishikawa, Y., Kato, Y., Mori, T., Machinami, R., Kitagawa, T., Alpha-particle-dose to the liver and spleen tissues of Japanese Thorotrast patients. Health Phys. 65 (1993), 497-506.
6. Kaul, A., Noffz, Z., Tissue dose in Thorotrast patients. Health Phys. 35 (1978), 113-121.
7. Ishikawa, Y., Humphreys, J.A.H., Collier, C.G., Priest, N.D., Kato, Y., Mori, T., Machinami, R., Revised organ partition of Th-232 in Thorotrast patients. Radiat. Res. 152 (1999), S102–S106.
8. Mori, T., Fukutomi, K., Kato, Y., Hatakeyama, S., Machinami, R., Tanooka, H., Ishikawa, Y., Kumatori, T., 1998 results of the first series of follow-up studies on Japanese Thorotrast patients and their relation to the autopsy series. Radiat. Res. 152 (1999), S72–S80.
9. Kamiyama, R., Ishikawa, Y., Hatakeyama, S., Mori, T., Sugiyama, H., Clinicopathological study of hematological disorders after Thorotrast administration in Japan. Blut 56 (1988), 153-160.
10. Ishikawa, Y., Mori, T., Kato, Y., Machinami, R., Priest, N.D., Kitagawa, T., Systemic deposits of thorium in Thorotrast patients with particular reference to sites of minor storage. Radiat. Res. 135 (1993), 244-248.
11. Andersson, M., Juel, K., Ishikawa, Y., Storm, H., Effects of preconceptional irradiation on mortality and cancer incidence in the offspring of patients injected with thorium dioxide. J. Natl. Cancer Inst. 86 (1994), 1866-1870.
12. Wada, I., Horiuchi, H., Mori, M., Ishikawa, Y., Fukumoto, M., Mori, T., Kato, Y., Kitagawa, T., Machinami, R., High rate of small p53 mutations and infrequent loss of heterozygosity in malignant liver tumors associated with Thorotrast: implications for alpha-particle carcinogenesis. Radiat. Res. 152 (1999), S125–S127.